Patient-Based Analysis
| Site of disease | 64CuCl2 PET/CT | 18F-choline PET/CT | P* | mpMRI | P* |
| All positive patients | 41/50 (82%) (69–91) | 28/50 (56%) (41–70) | <0.001 | 37/50 (74%) (60–85) | 0.3 |
| Local | 32/50 (64%) (49–77) | 15/50 (30%) (18–45) | <0.001 | 25/50 (50%) (36–64) | 0.07 |
| Lymph node | 16/50 (32%) (20–47) | 15/50 (30%) (18–45) | 1.0 | 14/50 (28%) (16–43) | 0.6 |
| Bone | 4/50 (8%) (2–19) | 4/50 (8%) (2–19) | 1.0 | 5/50 (10%) (3–22) | 1.0 |
↵* McNemar test vs. 64CuCl2 PET/CT.
Data are DR followed by percentage and 95% confidence interval for each diagnostic modality at each site of disease.